Arthur He
Stock Analyst at HC Wainwright & Co.
(1.14)
# 3,593
Out of 4,876 analysts
65
Total ratings
33.9%
Success rate
-14.32%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arthur He
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Maintains: Buy | $6.5 → $120 | $26.85 | +346.93% | 4 | Jun 24, 2025 | |
| SLDB Solid Biosciences | Reiterates: Buy | $20 | $4.77 | +319.29% | 10 | Jun 17, 2025 | |
| VERA Vera Therapeutics | Maintains: Buy | $75 → $85 | $23.19 | +266.54% | 2 | Jun 2, 2025 | |
| PRME Prime Medicine | Downgrades: Neutral | n/a | $2.53 | - | 8 | May 20, 2025 | |
| ADAG Adagene | Reiterates: Buy | $8 | $1.92 | +316.67% | 10 | Apr 3, 2025 | |
| ADAP Adaptimmune Therapeutics | Maintains: Buy | $3.5 → $3 | $0.24 | +1,171.19% | 6 | Apr 1, 2025 | |
| BCAB BioAtla | Reiterates: Neutral | n/a | $0.38 | - | 8 | Mar 31, 2025 | |
| LVTX LAVA Therapeutics | Reiterates: Neutral | $1.5 | $1.31 | +14.50% | 10 | Mar 31, 2025 | |
| HOOK HOOKIPA Pharma | Downgrades: Neutral | n/a | $1.24 | - | 7 | Jan 10, 2025 |
Nektar Therapeutics
Jun 24, 2025
Maintains: Buy
Price Target: $6.5 → $120
Current: $26.85
Upside: +346.93%
Solid Biosciences
Jun 17, 2025
Reiterates: Buy
Price Target: $20
Current: $4.77
Upside: +319.29%
Vera Therapeutics
Jun 2, 2025
Maintains: Buy
Price Target: $75 → $85
Current: $23.19
Upside: +266.54%
Prime Medicine
May 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.53
Upside: -
Adagene
Apr 3, 2025
Reiterates: Buy
Price Target: $8
Current: $1.92
Upside: +316.67%
Adaptimmune Therapeutics
Apr 1, 2025
Maintains: Buy
Price Target: $3.5 → $3
Current: $0.24
Upside: +1,171.19%
BioAtla
Mar 31, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.38
Upside: -
LAVA Therapeutics
Mar 31, 2025
Reiterates: Neutral
Price Target: $1.5
Current: $1.31
Upside: +14.50%
HOOKIPA Pharma
Jan 10, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.24
Upside: -